End Drug Shortages Act

Bill 118 s 5368, also known as the Drug Shortage Notification Act, aims to amend the Federal Food, Drug, and Cosmetic Act to address drug shortages caused by sudden increases in demand. The bill proposes expanding current drug shortage notification practices to include instances where there is a surge in demand for a particular drug.

The main goal of this legislation is to improve the communication and coordination between drug manufacturers, healthcare providers, and regulatory agencies in order to better respond to and prevent drug shortages. By requiring timely notification of surges in demand for drugs, the bill seeks to ensure that appropriate measures can be taken to address potential shortages and minimize their impact on patient care.

In addition to expanding notification practices, the bill also includes provisions for the establishment of a task force to study the root causes of drug shortages and develop recommendations for preventing future shortages. This task force would be responsible for identifying potential solutions and best practices for addressing drug shortages, with the ultimate goal of improving the availability and accessibility of essential medications for patients. Overall, Bill 118 s 5368 represents a bipartisan effort to address the growing issue of drug shortages in the United States by enhancing notification practices and promoting collaboration among stakeholders in the healthcare industry. If passed, this legislation has the potential to improve the resilience of the drug supply chain and ensure that patients have access to the medications they need.